These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 24797065)
1. Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy. Accogli M; Giani T; Monaco M; Giufrè M; García-Fernández A; Conte V; D'Ancona F; Pantosti A; Rossolini GM; Cerquetti M J Antimicrob Chemother; 2014 Aug; 69(8):2293-6. PubMed ID: 24797065 [No Abstract] [Full Text] [Related]
2. Emergence of Escherichia coli Sequence Type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a Long-Term Care and Rehabilitation Facility (LTCRF) in Northern Italy. Piazza A; Caltagirone M; Bitar I; Nucleo E; Spalla M; Fogato E; D'Angelo R; Pagani L; Migliavacca R Adv Exp Med Biol; 2016; 901():77-89. PubMed ID: 26810233 [TBL] [Abstract][Full Text] [Related]
4. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations. Vingopoulou EI; Siarkou VI; Batzias G; Kaltsogianni F; Sianou E; Tzavaras I; Koutinas A; Saridomichelakis MN; Sofianou D; Tzelepi E; Miriagou V J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836 [TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG; J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Simner PJ; Zhanel GG; Pitout J; Tailor F; McCracken M; Mulvey MR; Lagacé-Wiens PR; Adam HJ; Hoban DJ; Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961 [TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Goren MG; Navon-Venezia S; Chmelnitsky I; Carmeli Y Antimicrob Agents Chemother; 2010 Jun; 54(6):2687-91. PubMed ID: 20231393 [TBL] [Abstract][Full Text] [Related]
8. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922 [TBL] [Abstract][Full Text] [Related]
9. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. Ensor VM; Shahid M; Evans JT; Hawkey PM J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956 [TBL] [Abstract][Full Text] [Related]
10. First characterization of fluoroquinolone resistance mechanisms in CTX-M-producing Escherichia coli from Mongolia. Kao CY; Udval U; Wu HM; Bolormaa E; Yan JJ; Khosbayar T; Wu JJ Infect Genet Evol; 2016 Mar; 38():79-81. PubMed ID: 26692472 [No Abstract] [Full Text] [Related]
11. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan. Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014 [TBL] [Abstract][Full Text] [Related]
12. Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in Spain. Porres-Osante N; Azcona-Gutiérrez JM; Rojo-Bezares B; Undabeitia E; Torres C; Sáenz Y J Antimicrob Chemother; 2014 Jul; 69(7):1792-5. PubMed ID: 24583362 [TBL] [Abstract][Full Text] [Related]